- Thinly traded micro cap CytoSorbents (NASDAQ:CTSO +5.6%) is up almost double normal volume. Shares have rallied 20% in a week.
- On Monday, May 14, it announced that European regulators approved the expanded use of its CytoSorb filter to now include reducing elevated bilirubin and myoglobin from blood, a substantial market opportunity considering the millions of people suffering from chronic liver disease.
CytoSorbents adds to CytoSorb expanded use-stoked rally, shares up 6%
Recommended For You
More Trending News
About CTSO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CTSO | - | - |
Cytosorbents Corporation |